Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Sunitinib Malate Capsules

Approval Number

国药准字H20234099

Company吉林敖东洮南药业股份有限公司

Registration Date

September 5, 2023

Drug Information

Generic Name

苹果酸舒尼替尼胶囊

Dosage Form

胶囊剂

Strength

12.5mg（按 C₂₂H₂₇FN₄O₂计）

Drug Type

化学药品

Registration Date

September 5, 2023

Company Information

Applicant Company

Company Name吉林敖东洮南药业股份有限公司

Company Address

吉林省洮南经济开发区兴业路2999号

Manufacturing Company

Company Name吉林敖东洮南药业股份有限公司

Company Address

吉林省洮南经济开发区兴业路2999号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy